Correlation
The correlation between UTMD and DHR is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
UTMD vs. DHR
Compare and contrast key facts about Utah Medical Products, Inc. (UTMD) and Danaher Corporation (DHR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: UTMD or DHR.
Performance
UTMD vs. DHR - Performance Comparison
Loading data...
Key characteristics
UTMD:
-0.87
DHR:
-0.81
UTMD:
-1.42
DHR:
-1.12
UTMD:
0.83
DHR:
0.85
UTMD:
-0.33
DHR:
-0.66
UTMD:
-1.09
DHR:
-1.42
UTMD:
16.89%
DHR:
18.50%
UTMD:
18.83%
DHR:
30.34%
UTMD:
-55.58%
DHR:
-65.30%
UTMD:
-52.72%
DHR:
-34.56%
Fundamentals
UTMD:
$178.91M
DHR:
$136.31B
UTMD:
$3.80
DHR:
$5.15
UTMD:
14.49
DHR:
36.87
UTMD:
0.00
DHR:
1.86
UTMD:
4.56
DHR:
5.72
UTMD:
1.51
DHR:
2.67
UTMD:
$39.27M
DHR:
$23.82B
UTMD:
$22.41M
DHR:
$14.23B
UTMD:
$14.66M
DHR:
$7.17B
Returns By Period
In the year-to-date period, UTMD achieves a -9.91% return, which is significantly higher than DHR's -17.15% return. Over the past 10 years, UTMD has underperformed DHR with an annualized return of 1.74%, while DHR has yielded a comparatively higher 18.26% annualized return.
UTMD
-9.91%
5.52%
-14.72%
-17.79%
-12.50%
-9.59%
1.74%
DHR
-17.15%
-3.46%
-20.56%
-25.70%
-6.30%
5.57%
18.26%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
UTMD vs. DHR — Risk-Adjusted Performance Rank
UTMD
DHR
UTMD vs. DHR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Utah Medical Products, Inc. (UTMD) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
UTMD vs. DHR - Dividend Comparison
UTMD's dividend yield for the trailing twelve months is around 2.20%, more than DHR's 0.60% yield.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
UTMD Utah Medical Products, Inc. | 2.20% | 1.96% | 1.41% | 1.16% | 2.86% | 1.33% | 1.02% | 1.31% | 1.31% | 1.44% | 1.75% | 1.67% |
DHR Danaher Corporation | 0.60% | 0.47% | 0.43% | 0.38% | 0.26% | 0.32% | 0.44% | 0.62% | 0.60% | 36.46% | 0.80% | 0.47% |
Drawdowns
UTMD vs. DHR - Drawdown Comparison
The maximum UTMD drawdown since its inception was -55.58%, smaller than the maximum DHR drawdown of -65.30%. Use the drawdown chart below to compare losses from any high point for UTMD and DHR.
Loading data...
Volatility
UTMD vs. DHR - Volatility Comparison
The current volatility for Utah Medical Products, Inc. (UTMD) is 4.67%, while Danaher Corporation (DHR) has a volatility of 12.02%. This indicates that UTMD experiences smaller price fluctuations and is considered to be less risky than DHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
UTMD vs. DHR - Financials Comparison
This section allows you to compare key financial metrics between Utah Medical Products, Inc. and Danaher Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UTMD vs. DHR - Profitability Comparison
UTMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Utah Medical Products, Inc. reported a gross profit of 5.54M and revenue of 9.71M. Therefore, the gross margin over that period was 57.0%.
DHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Danaher Corporation reported a gross profit of 3.51B and revenue of 5.74B. Therefore, the gross margin over that period was 61.2%.
UTMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Utah Medical Products, Inc. reported an operating income of 3.15M and revenue of 9.71M, resulting in an operating margin of 32.5%.
DHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Danaher Corporation reported an operating income of 1.27B and revenue of 5.74B, resulting in an operating margin of 22.2%.
UTMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Utah Medical Products, Inc. reported a net income of 3.04M and revenue of 9.71M, resulting in a net margin of 31.3%.
DHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Danaher Corporation reported a net income of 954.00M and revenue of 5.74B, resulting in a net margin of 16.6%.